# TRAF5

## Overview
TRAF5 is a gene that encodes the TNF receptor associated factor 5, a protein that plays a pivotal role in immune signaling pathways. The TRAF5 protein is categorized as an adaptor protein, which is integral to the transduction of signals from the TNF receptor superfamily, including CD40, CD27, and GITR, among others. These interactions are crucial for the regulation of immune responses, particularly in lymphocyte activation and survival (hildebrand2011roles). Structurally, TRAF5 is characterized by an N-terminal RING finger domain, zinc finger motifs, and a C-terminal TRAF domain, which facilitate its function in receptor interaction and signal transduction (hildebrand2011roles; Park2018Structure). The protein's ability to form homotypic and heterotypic multimers enhances its role in modulating complex signaling networks within the immune system (hildebrand2011roles). Variations in the TRAF5 gene have been associated with several autoimmune and inflammatory diseases, underscoring its clinical significance in immune regulation (Xu2021Association; Hikosaka2023Role).

## Structure
TRAF5 is a protein composed of 557 amino acids and is located on chromosome 1 in humans (hildebrand2011roles). Its molecular structure includes several distinct domains: an N-terminal RING finger domain, which is important for E3 ubiquitin ligase activity, five zinc finger motifs, and a C-terminal TRAF domain (hildebrand2011roles; Park2018Structure). The TRAF domain is subdivided into the TRAF-N and TRAF-C domains. The TRAF-N domain is a coiled-coil structure, while the TRAF-C domain consists of seven to eight anti-parallel β-sheet folds (Park2018Structure).

TRAF5 forms a stable trimer in solution, with the TRAF-C domain forming the cap and the TRAF-N domain forming the stalk, resembling a mushroom shape (WU1999Structural; Park2018Structure). This trimeric structure is crucial for its function in receptor interaction and signal transduction (WU1999Structural). The protein can form homotypic multimers or heterotypic multimers with TRAF3 through interactions via the TRAF-N domain (hildebrand2011roles).

TRAF5 shares conserved residues in interaction hot spots with other TRAF family members, indicating similar receptor specificity and interaction modes (Park2018Structure). The electrostatic surface characteristics of TRAF5 allow it to accommodate diverse receptors, similar to TRAF1, TRAF2, and TRAF3 (Park2018Structure).

## Function
TRAF5 (TNF receptor associated factor 5) is a protein that plays a significant role in immune cell signaling and regulation. It is involved in several key signaling pathways, including those mediated by CD40, CD27, and GITR, which are crucial for lymphocyte activation and T cell expansion and survival in response to infection (hildebrand2011roles). TRAF5 acts as a critical intermediate in costimulatory signaling pathways and is necessary for optimal T cell function (hildebrand2011roles).

In B cells, TRAF5 is required for CD40-mediated signaling, which is important for B cell proliferation and function (hildebrand2011roles). It also plays a role in the regulation of NF-kB and JNK pathways, which are essential for immune response regulation and cell survival (hildebrand2011roles).

TRAF5 is involved in the IL-17A signaling pathway, where it interacts with 14-3-3ζ to modulate IL-6 production, acting as a suppressor of IL-17A-induced IL-6 induction (McGowan20201433ζ–TRAF5). This interaction highlights its role in modulating inflammatory responses and maintaining immune homeostasis (McGowan20201433ζ–TRAF5).

TRAF5 is primarily active in the cytoplasm, where it forms complexes with other TRAF proteins to enhance signaling complexity and regulate immune cell functions (hildebrand2011roles).

## Clinical Significance
Mutations and alterations in the expression of the TRAF5 gene have been implicated in various inflammatory and autoimmune diseases. In ankylosing spondylitis (AS), the TRAF5 gene promoter is highly methylated, leading to reduced mRNA expression, which may contribute to the disease's pathogenesis (Xu2021Association; Hikosaka2023Role). Genetic variants of TRAF5 are associated with rheumatoid arthritis (RA), with a significant association found between the SNP rs7514863 and RA susceptibility (Potter2007Investigation). Specific single nucleotide polymorphisms (SNPs) in TRAF5 are also linked to uveitis, Vogt-Koyanagi-Harada syndrome, and Behçet's disease, suggesting that TRAF5 polymorphisms increase the risk for these conditions (Hikosaka2023Role; Xiang2013TNF).

Decreased TRAF5 expression is observed in Sjögren syndrome (SS) and systemic lupus erythematosus (SLE), where it may enhance TLR7 signaling and promote autoreactive B cells (Hikosaka2023Role). TRAF5 is also involved in glucocorticoid-induced TNFR family-related protein (GITR) signaling, affecting T cell proliferation and cytokine production, which can influence inflammatory responses (Hikosaka2023Role). These findings highlight the clinical significance of TRAF5 in the context of immune regulation and its potential role in the pathogenesis of various autoimmune and inflammatory diseases.

## Interactions
TRAF5 is involved in various protein interactions that are crucial for its role in immune signaling pathways. It primarily interacts with members of the TNF receptor superfamily, such as CD40, CD27, and CD30, to mediate NF-κB and MAPK signaling pathways (hildebrand2011roles; Hauer2005TNF). TRAF5 forms complexes with other TRAF proteins, including TRAF2 and TRAF3, which are essential for the activation of both canonical and noncanonical NF-κB pathways (hildebrand2011roles; Hauer2005TNF).

TRAF5 is a positive regulator of signaling downstream of T-cell costimulatory receptors like CD27, GITR, and OX40, and is critical for T cell expansion and survival during infections (hildebrand2011roles). In B cells, TRAF5 is necessary for CD40-mediated proliferation and antibody production, and it plays a role in limiting Th2 immune responses (hildebrand2011roles).

TRAF5 also interacts with the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1), where it is recruited by TRAF3 to enhance LMP1 signaling in B cells (hildebrand2011roles). These interactions highlight TRAF5's involvement in regulating immune responses and its potential role in the pathogenesis of autoimmune diseases (Shen2013Upregulation).


## References


1. (hildebrand2011roles) Joanne M Hildebrand, Zuoan Yi, Claire M Buchta, Jayakumar Poovassery, Laura L Stunz, and Gail A Bishop. Roles of tumor necrosis factor receptor associated factor 3 (traf3) and traf5 in immune cell functions. Immunological reviews, 244(1):55–74, 2011. This article has 116 citations and is from a domain leading peer-reviewed journal.

[2. (McGowan20201433ζ–TRAF5) Jenna McGowan, Cara Peter, Joshua Kim, Sonam Popli, Brent Veerman, Jessica Saul-McBeth, Heather Conti, Shondra M. Pruett-Miller, Saurabh Chattopadhyay, and Ritu Chakravarti. 14-3-3ζ–traf5 axis governs interleukin-17a signaling. Proceedings of the National Academy of Sciences, 117(40):25008–25017, September 2020. URL: http://dx.doi.org/10.1073/pnas.2008214117, doi:10.1073/pnas.2008214117. This article has 19 citations.](https://doi.org/10.1073/pnas.2008214117)

[3. (Hikosaka2023Role) Mari Hikosaka Kuniishi, Naoto Ishii, and Takanori So. Role of tumor necrosis factor receptor-associated factor 5 in b- and t-lymphocytes. Exploration of Immunology, pages 40–55, February 2023. URL: http://dx.doi.org/10.37349/ei.2023.00088, doi:10.37349/ei.2023.00088. This article has 1 citations.](https://doi.org/10.37349/ei.2023.00088)

[4. (Park2018Structure) Hyun H. Park. Structure of traf family: current understanding of receptor recognition. Frontiers in Immunology, August 2018. URL: http://dx.doi.org/10.3389/fimmu.2018.01999, doi:10.3389/fimmu.2018.01999. This article has 114 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2018.01999)

[5. (Potter2007Investigation) C. Potter, S. Eyre, A. Cope, J. Worthington, and A. Barton. Investigation of association between the traf family genes and ra susceptibility. Annals of the Rheumatic Diseases, 66(10):1322–1326, October 2007. URL: http://dx.doi.org/10.1136/ard.2006.065706, doi:10.1136/ard.2006.065706. This article has 38 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1136/ard.2006.065706)

[6. (Xiang2013TNF) Qin Xiang, Lu Chen, Jing Fang, Shengping Hou, Lin Wei, Lin Bai, Yunjia Liu, Yan Zhou, Aize Kijlstra, and Peizeng Yang. Tnf receptor-associated factor 5 gene confers genetic predisposition to acute anterior uveitis and pediatric uveitis. Arthritis Research &amp; Therapy, September 2013. URL: http://dx.doi.org/10.1186/ar4293, doi:10.1186/ar4293. This article has 30 citations.](https://doi.org/10.1186/ar4293)

[7. (WU1999Structural) H. WU, Y.C. PARK, H. YE, and L. TONG. Structural studies of human traf2. Cold Spring Harbor Symposia on Quantitative Biology, 64(0):541–550, January 1999. URL: http://dx.doi.org/10.1101/SQB.1999.64.541, doi:10.1101/sqb.1999.64.541. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1101/SQB.1999.64.541)

[8. (Xu2021Association) Shanshan Xu, Xing Gao, Yubo Ma, Jixiang Deng, Shengqian Xu, and Faming Pan. Association of methylation level and transcript level in traf5 gene with ankylosing spondylitis: a case-control study. Genes &amp; Immunity, 22(2):101–107, May 2021. URL: http://dx.doi.org/10.1038/s41435-021-00135-7, doi:10.1038/s41435-021-00135-7. This article has 9 citations.](https://doi.org/10.1038/s41435-021-00135-7)

[9. (Shen2013Upregulation) Jun Shen, Yu-qi Qiao, Zhi-hua Ran, and Tian-rong Wang. Up-regulation and pre-activation of traf3 and traf5 in inflammatory bowel disease. International Journal of Medical Sciences, 10(2):156–163, 2013. URL: http://dx.doi.org/10.7150/ijms.5457, doi:10.7150/ijms.5457. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/ijms.5457)

[10. (Hauer2005TNF) Julia Hauer, Stephanie Püschner, Parameswaran Ramakrishnan, Ute Simon, Martina Bongers, Christine Federle, and Hartmut Engelmann. Tnf receptor (tnfr)-associated factor (traf) 3 serves as an inhibitor of traf2/5-mediated activation of the noncanonical nf-κb pathway by traf-binding tnfrs. Proceedings of the National Academy of Sciences, 102(8):2874–2879, February 2005. URL: http://dx.doi.org/10.1073/pnas.0500187102, doi:10.1073/pnas.0500187102. This article has 309 citations.](https://doi.org/10.1073/pnas.0500187102)